THE MONOAMINE-OXIDASE INHIBITING PROPERTIES OF CGP-11305-A

被引：73

作者：

WALDMEIER, PC ^{[1
]}

FELNER, AE ^{[1
]}

TIPTON, KF ^{[1
]}

机构：

[1] UNIV DUBLIN TRINITY COLL,DEPT BIOCHEM,DUBLIN,IRELAND

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1983年 / 94卷 / 1-2期

关键词：

D O I：

10.1016/0014-2999(83)90443-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：73 / 83

页数：11

共 18 条

[1]

DAVIS JM, 1973, PSYCHIAT ANN, V3, P6

[2]

Dixon M., 1979, ENZYMES, P332

[3]

FELNER AE, 1979, BIOCHEM PHARMACOL, V28, P995, DOI 10.1016/0006-2952(79)90293-4

[4] TYRAMINE ANTAGONISTIC PROPERTIES OF AGN-1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE TYPE-B [J].

FINBERG, JPM ;

TENNE, M ;

YOUDIM, MBH .

BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (01) :65-74

[5] MONOAMINE-OXIDASE A AND B - USEFUL CONCEPT [J].

FOWLER, CJ ;

CALLINGHAM, BA ;

MANTLE, TJ ;

TIPTON, KF .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) :97-101

[6] REACTION PATHWAY OF MEMBRANE-BOUND RAT-LIVER MITOCHONDRIAL MONOAMINE-OXIDASE [J].

HOUSLAY, MD ;

TIPTON, KF .

BIOCHEMICAL JOURNAL, 1973, 135 (04) :735-750

[7] COMPARATIVE BEHAVIORAL-EFFECTS OF CLORGYLINE AND PARGYLINE IN MAN - PRELIMINARY EVALUATION [J].

LIPPER, S ;

MURPHY, DL ;

SLATER, S ;

BUCHSBAUM, MS .

PSYCHOPHARMACOLOGY, 1979, 62 (02) :123-128

[8]

MAITRE L, 1976, CIBA F S, V39, P247

[9]

MARLEY E, 1977, DRUG INTERACTIONS, P171

[10]

Neff N H, 1972, Adv Biochem Psychopharmacol, V5, P307

← 1 2 →